Učitavanje...
Reduction of glycemic variability with Degludec insulin in patients with unstable diabetes
INTRODUCTION: Degludec (IDeg) is an ultralong-acting insulin, with stable pharmacodynamic profile which leads to lower fluctuations in glucose levels. The effect of IDeg has not been specifically assessed in patients with unstable diabetes, defined as increased glycemic variability (GV). METHODS: A...
Spremljeno u:
| Izdano u: | J Clin Transl Endocrinol |
|---|---|
| Glavni autori: | , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Elsevier
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5992319/ https://ncbi.nlm.nih.gov/pubmed/29892561 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcte.2018.03.003 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|